Jakob Dupont, EVP, Head of R&D at Atara Biotherapeutics, Inc. (ATRA), sold 4,342 shares at $4.49 ($19K) on 2022-11-16, disclosed to the SEC on 2022-11-18.
Scheduled sale ($19k) by EVP, Head of R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.49 | 1,124 | $5K | 25.9% |
| 2 | $4.49 | 3,218 | $14K | 74.1% |
| Total | $4.49 avg | 4,342 | $19K | 100% |
| Filing → |
| ATRA | SELL | 2022-08-18 | $21K | — | Filing → |
| ATRA | SELL | 2022-05-19 | $21K | — | Filing → |
| ATRA | SELL | 2022-03-03 | $22K | — | Filing → |